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ABSTRACT 
Background 
Interventional treatment of chronic total coronary occlusions (CTOs) is a developing 
subspecialty. Predictors of technical success or failure have been derived from datasets of 
modest size. A robust scoring tool could facilitate case selection and inform decision making. 
Methods  
We analysed data from the EuroCTO Registry. This prospective database was set up in 2008 
and includes >20,000 cases submitted by CTO expert operators (>50 cases/yr). Derivation 
(n=14,882) and Validation (n=5,745) datasets were created to develop a risk score for 
predicting technical failure. 
Results 
There were 14,882 patients in the derivation dataset (with 2356 (15.5%) failures) and 5,745 in 
the validation dataset (with 703 (12.2%) failures). 20.2% of cases were done retrogradely and 
dissection re-entry was performed in 9.3% of cases. We identified six predictors of technical 
failure – CABG history, Age (≥70yrs), Stump anatomy (blunt or invisible), Tortuosity degree 
(severe or unseen), Length of occlusion (≥20 mm) and Extent of calcification (severe). 
Collectively these form the CASTLE score. When each parameter was assigned a value of 1, 
technical failure was seen to increase from 8% with a CASTLE score of 0-1, to 35% with a 
score ≥4. The area under the curve (AUC) was similar in both the derivation (AUC = 0.66) and 
validation sets (AUC = 0.68).  
Conclusions 
The EuroCTO (CASTLE) score is derived from the largest database of CTO cases to date and 
offers a useful tool for predicting procedural outcome.  
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CONDENSED ABSTRACT 
Interventional treatment of chronic total occlusions (CTO) is a developing subspecialty. We 
examined data from the EuroCTO Registry of 20,000 prospectively-entered cases from 
dedicated CTO operators. Derivation and Validation datasets were created and subjected to 
analysis. A simple integer scoring system was created to predict procedural outcome. The 
simple score suggests that the following factors are of greatest importance: CABG history; Age; 
Stump anatomy; Tortuosity degree; Length of occlusion and Extent of calcification (CASTLE). 
Technical failure rates range from 8% (CASTLE score 0-1) to 35% (CASTLE score ≥4).  
  
 6 
INTRODUCTION 
Chronic total occlusions (CTO) are present in approximately one-fifth of patients undergoing 
coronary angiography1. Historically, these lesions have often been managed either with medical 
therapy or with coronary artery bypass grafting in suitable candidates because of their 
complexity and low interventional success rates. Percutaneous coronary intervention (PCI) of 
CTOs has become more widely accepted in the last decade, with increasing success rates related 
to operator experience, guidewire technology and microcatheter sophistication2. Despite these 
improvements, procedural success rates remain lower than those achieved with non-occlusive 
lesions.3 . A simple and accurate scoring tool to grade the difficulty of cases would be valuable 
for appropriate case selection and planning. Attempts have been made to classify procedures 
according to their likelihood of success based on patient, lesion and procedural features4,5. 
These however have been derived from a relatively modest number of patients, and 
consequently their predictive ability has not been uniformly consistent6. Additionally, some 
have focussed purely on the antegrade approach, to the exclusion of retrograde possibilities7. 
Using the EuroCTO registry, we analysed the factors influencing technical success and we 
derived and validated a simple model to predict successful percutaneous treatment of CTOs. 
 
 
METHODS 
Patient population 
The EuroCTO club is a collaborative effort amongst high volume CTO operators in Europe 
aimed at sharing experiences and outcomes data. Since 2008, patient characteristics and 
procedural data have been prospectively recorded in a dedicated registry (www.ercto.org) by 
individual members. In this database multiple variables are recorded for every patient regarding 
preprocedural demographic and anatomical characteristics, procedural details and 
postprocedural outcomes. The data for this analysis relate to patients in whom CTO 
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recanalization was attempted between 2008 and 2016 in 55 European centres. The aim of the 
analysis was to develop a scoring system to predict the likelihood of success of CTO PCI.   
 
Definitions 
Coronary CTOs were defined as occlusions of greater than 3 months duration with TIMI 
(Thrombolysis in Myocardial Infarction) grade 0 intralesional coronary flow8. The length of 
coronary occlusions was estimated from angiographic projections visually with single or dual 
contrast injections. The degree of calcification was visually estimated on fluoroscopy - 
moderate calcification was considered to be present if half of the total CTO segment had visible 
residues; extension of calcification to >50% of the segment was considered to be severe. The 
CTO was defined as straight if the pre-occlusive segment contained a bend of <70 degrees. 
Moderate tortuosity was defined as a segment containing either 2 bends > 70 degrees or 1 bend 
>90 degrees.  A severely tortuous CTO vessel contained either 2 or more pre-occlusive bends of 
>90 degrees or at least 1 bend of >120 degrees. The morphology of the vessel stump was 
classified as tapered, blunt or unseen depending on its appearance on fluoroscopy. The 
angiographic assessment of collateral connections was made according to the Werner 
classification9.  Opacification beyond the occlusion was classified into either none, faint or 
good. Good distal visibility was defined as distal opacification comparable to the proximal 
segment. Technical success was defined as a residual stenosis of<10% at the end of the 
procedure with TIMI 3 antegrade flow.    
 
Statistical methods 
Predictive model development 
The aim was to develop an accurate predictive model from a large number of potential risk 
factors in order to provide robust prediction of success or failure of CTO PCI. Potential 
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predictive factors strongly associated with the failure of the procedure were selected from 
candidate variables with univariate logistic regression analysis. These variables included patient 
characteristics and medical history, baseline measurements and lesion characteristics. Given the 
large number of patients and outcomes important independent clinical predictors were identified 
using a stepwise approach with p< 0.01 as the inclusion criterion. Using multiple imputed data 
to account for missing values, patients’ demographic data and medical history variables were 
first entered into the logistic regression model. Baseline measurements and lesion 
characteristics were then added to the model and evaluated using the pre-set p value of < 0.01 
for variable retention. In the final stage variables initially excluded were sequentially re-entered 
into the model and were re-assessed using the pre-set inclusion criteria.  
 
Multiple imputations 
There were no missing values for the outcome of the CTO procedure but data were missing for 
potential predictor variables (<10% for each variable). In order to adjust for these missing data, 
multiple imputation techniques with chained equations were used, assuming missingness is at 
random, with 20 imputations using all covariates showing an association (p<0.01) including the 
outcome variable of technical success, smoking status, gender, CTO location and collateral 
circulation10. The variables included in the final model were also imputed on the validation set 
using the same multiple imputation techniques. 
 
Risk score analyses 
The 2008-2014 cohort was available initially to develop the risk score. The 2015-2016 cohort 
was used for the validation of the model when these data became available and also to help 
establish whether success rates had improved over time.  The coefficients in the final logistic 
model can be used to develop a detailed risk score to predict the probability of failure for each 
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patient. However, the aim of our analysis was to develop and present a simplified, easy to use 
risk score for predicting failure. The multivariable predictive model was converted into a simple 
risk score by allocating a 0/1 score for each variable in the model depending on the value of that 
variable for each individual. For each risk factor the category with the lowest predicted risk (i.e. 
the most beneficial group) was allocated a score of 0 together with any categories with a 
coefficient <0.20 in the model. A score of 1 was assigned to categories where the coefficient 
was ≥0.20 from the multivariable logistic regression model (which equates to an odds ratio of 
1.22). The total risk score for each individual in the cohort was then computed by adding up the 
assigned scores for each factor. The distribution of the patients’ total risk scores was split into 
four risk groups for comparison of observed and predicted probabilities of failure to ensure a 
reasonable number of events in each risk group. On the validation set the same scoring systems 
were applied as on the derivation set in order to classify the patients into different levels of risk 
categories.    
 
Model performance 
The model performance was inspected on the imputed data with the Hosmer-Lemeshow statistic 
comparing the observed and predicted probabilities of the patients in groups defined by their 
predicted probabilities and with the area under curve (AUC) quantifying the ability of the model 
to discriminate patients at high risk from patients at low risk. Overall model performance on the 
validation set was assessed with the Brier score11.   
The regression coefficients from the derivation dataset from the logistic model containing the 0-
6 patient risk score were applied to compute the predicted risk of failure of PCI for patients in 
the validation set.  To correct for the improvement in success rates in the 2015-2016 cohort 
compared to the 2008-2014 cohort, an adjustment was made by including the year of operation 
as a covariate into the model. This allowed for an assessment of the validity of the risk score 
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while presenting better current estimates of actual predicted risks of failure. Risk scores for the 
validation dataset were calculated in exactly the same way as for the derivation dataset i.e. by 
allocating a score of 0 or 1 for each of the six variables in the model and summing across 
variables.   
Comparison with J-CTO scoring system 
We explored the discriminative capacity of the commonly utilised J-CTO score4 in our dataset. 
Score of 1 was first allocated to J-CTO variables of previously failed lesion, blunt/no stump, 
bending, severe calcification, occlusion length ≥ 20mm. The total risk scores were then 
obtained on both derivation and validation sets. The discriminative performance of J-CTO 
scoring system was assessed using ROC curves within both the derivation and validation data 
sets.   
 
RESULTS 
 
Procedural characteristics 
In 76.1% of cases, PCI-CTO was attempted for the first time while 3.7% of cases had had more 
than two previous failed attempts. Contralateral injection was used in half of the cases. The 
majority of the cases were done using either 6Fr (42.8%) or 7Fr guide catheters (44.5%). 
Intravascular imaging with IVUS was performed in 7.4% of cases. The antegrade approach was 
attempted in 86.1% of cases and was successful in 82.7% of those cases. The single wire 
technique was commonly successful in recanalization being used in over 75.7% of cases. This 
was followed by the parallel wire technique (16.8% of successful cases). Dissection re-entry 
techniques were used in a minority of antegrade cases (2.1%). A retrograde strategy was utilised 
in 20.2% in our cohort with this approach being used a priori in 13.9%. Touching wire was 
most commonly used (37.6%) followed by retrograde wire crossing (30.8%), reverse CART 
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(24.6%) and CART (7.0%). The overall success rate of the retrograde approach (including both 
upfront and bailout after failed antegrade technique) was 67.3%. 
 
Derivation of the Euro-CTO CASTLE risk analysis tool 
Of 14,882 patients in the derivation dataset (2008-14), 2,356 (15.8 %) had unsuccessful CTO 
PCI. In the validation dataset (2015-2016) there were 5745 patients with 703 (12.2%) who had 
an unsuccessful CTO PCI. Demographic and clinical variables were explored using the 
derivation dataset for their association with an unsuccessful CTO procedure (Table 1, SuppTab 
1-3).  
 
The derivation dataset had 10,760 patients with no missing values and 4122 patients with at 
least one missing value for the predictor variables which were imputed as described above. On 
multivariable analysis of 21 variables associated on univariable analysis, six were identified on 
the imputed dataset as strong independent predictors of failure of CTO PCI: these were previous 
CABG, Age, Stump anatomy, Tortuosity, Length of CTO and Extent of calcification 
(CASTLE). The estimated odds ratios (ORs) of the association between these variables and the 
failure of PCI are shown in Table 2.  Previous CABG, blunt or no stump, severe tortuosity, high 
level of calcification, occlusion greater than 20 mm and age above 70 years were all 
independently associated with an increased risk of failure of the intervention.  
 
To develop an easy to use scoring system able to identify patients at highest risk of CTO PCI 
failure a robust risk score was developed allocating 0 or 1 for each variable depending on which 
category a patient was in (Table 2, SuppTab4). The risk score was calculated by the simple 
addition across all variables.  
 
 12 
In order to compare observed and predicted risk for the simple risk score the total scores were 
grouped into four categories (Figure 2 and Table 3). The total risk scores and risk categories 
showed good separation of the failure rates across the risk groups. There were 18 unsuccessful 
PCI procedures in 34 patients with total risk score of 6 (52.9%) compared to 68 unsuccessful 
procedures in 1129 patients (6.0%) with risk score of 0, an eightfold increase in risk. Overall a 
good agreement was found between the observed and predicted risks within each group (Table 
3, Figure 2), demonstrating good model calibration. 
 
Using the CASTLE model with the identified predictive factors (Table 1) Hosmer-Lemeshow 
goodness-of-fit test revealed good agreement between the predicted and observed probabilities 
of failure of PCI (χ2 with degrees of freedom of 13 = 18.79, p = 0.1 for any imputed data set), 
demonstrating that the model was well-calibrated. The discriminating ability of the CASTLE 
model based on the robust scoring defined by the AUC of the total risk scores (AUC = 0.66) 
was reasonable to distinguish patients at low and high risk.   
 
Validation of Euro-CTO CASTLE risk analysis tool 
The distribution of the identified predictive variables by the outcome of the procedure on the 
validation Euro-CTO data set from years 2015 and 2016 is shown in SuppTab5. The validation 
dataset had 5258 patients with no missing values and 487 patients with at least one missing 
value for the predictor. The distribution of the total risk scores of patients in the imputed 
validation set (Figure 3a) was very similar to that on the derivation set (Figure 1). Although the 
model seems to overestimate the likelihood of failure of PCI to some extent (Figure 3b, 
SuppTab6, SuppTab7), this can largely be explained by the improved success rate over time. 
The overall rate of the observed failure of PCI on the derivation set (15.8 %, 2356/14482) was  
higher by 3.5 % than that on the validation set (12.2 %, 703/5745). A decreasing trend year on 
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year in the observed annual failure rates from years 2008 to 2016 was also revealed (p < 0.001) 
(Figure 4). Adjusting the CASTLE model for year of operation indeed proved that this 
improvement in the success of PCI helps to explain small discrepancies between the observed 
and predicted failure rates computed by the CASTLE algorithm on the validation set (Figure 5, 
SuppTab8). The overall model performance on the validation set quantified by the Brier-score 
(Brier score = 0.103 and 0.102 without and with the adjustment of the CASTLE model for year 
of operation, respectively) was reasonable. The concordance probability measured by the AUC 
was actually higher on the validation set (AUC = 0.68 for both unadjusted and adjusted models) 
when compared to the derivation set (AUC = 0.66). 
 
Comparison with J-CTO score 
The AUC of J-CTO scoring tool was 0.63 and 0.64 within the training and validation sets 
respectively. In comparison, our AUC showed a higher discriminatory capacity for both data 
sets (for the derivation set AUC=0.66; for the validation set AUC=0.68).  
 
DISCUSSION 
We present a simple scoring system to predict technical success when performing CTO PCI. 
Despite technical advances, CTO-PCI remains one of the most difficult areas of interventional 
cardiology and the one most likely to fail. Therefore being able to predict in advance the 
likelihood of success will help cardiologists choose wisely, in a number of important ways. 
Firstly it will help guide interventionalists during their learning phase as CTO operators in 
terms of case selection; Secondly it will aid Heart Team discussions regarding the likelihood of 
complete revascularisation with PCI or CABG; Thirdly it will aid comprehensive informed 
consent for patients regarding the likelihood of CTO PCI success.  
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A number of scoring systems have been developed over the years to predict successful PCI. 
Morino et al. publish the J-CTO score in 2011, derived from 400 CTO cases. This study 
identified five characteristics associated with failure to pass an antegrade guidewire across the 
occlusion within 30 minutes.4  The characteristics included a previous failed attempt and did not 
include previous CABG (widely recognised to be an adverse feature). While procedural failure 
has been shown to be associated with higher lesion scores in some studies, this relationship has 
not been observed consistently6.  
 
Alessandrino et al. published the single-centre CL-score which identified independent 
predictors of procedural failure in patients undergoing CTO-PCI for the first time.7 Two clinical 
variables (history of CABG and previous MI) and four lesion specific characteristics (blunt 
stump, lesion calcification, non-LAD CTO and lesion length>20mm) were found to be 
associated with an unsuccessful procedure.  
 
The PROGRESS score developed by Christopoulos et al. estimated the likelihood of success in 
CTO treated using a hybrid approach12. Four lesion characteristics - proximal cap ambiguity, 
moderate/severe tortuosity, circumflex artery CTO and the absence of retrograde collaterals 
were found to determine technical success.  
 
Maeremans et al recently published the RECHARGE score13. Six factors associated with 
technical failure were identified: a blunt stump, lesion calcification, in-lesion tortuosity ≥45°, 
lesion length >20 mm, a diseased distal landing zone and previous bypass graft on the CTO 
vessel. This score however was derived from 880 patients undergoing a particular approach to 
CTO treatment using the CrossBoss or Hybrid techniques, used relatively rarely in the 
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EuroCTO database. However, it is reassuring to see that some negative predictors remain 
consistent. 
 
The strength of the EuroCTO CASTLE score rests on the large and varied volume of patients 
from which it is derived and validated. Previous scoring systems have largely been single-
institution, based on the antegrade technique alone or based on relatively modest numbers of 
patients. This study uses patient numbers an order of magnitude greater, with cases undertaken 
by a large number of different operators across Europe, and should therefore reflect more 
accurately global practice and offer greater contemporary relevance. Previous scores have 
provided valuable insight into the predictors of failure. However, some of these are no longer 
contemporary, and our study demonstrates the importance of adjusting for improved success 
rates over time in predicting actual failure rates. Despite this change over time, the score 
performs well both in identifying predictors of procedural failure and demonstrating their 
persisting relevance.  
 
Our scoring system has a greater discriminative capacity compared to the widely used J-CTO 
score. The EuroCTO CASTLE score incorporates four factors that are included in the other two 
main general scoring systems – stump anatomy (J-CTO); tortuosity (J-CTO (in-lesion) and 
PROGRESS); length of occlusion (J-CTO and PROGRESS) and extent of calcification (J-CTO). 
Importantly however it also includes two additional variables – previous CABG and Age, both 
of which are objective and not open to operator interpretation. This enhances the functional 
integrity of the score. It is also noteworthy that the incidence of previous CABG was lower at 6% 
to 9% in the previous main scoring systems but was 13% in the EuroCTO Registry. This 
relatively higher prevalence helps justify why previous CABG merits consideration as an 
important variable. Although our score is broadly similar to published ones, our study confirms 
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the importance of previously identified predictors of CTO PCI success using contemporary data 
from a multitude of operators. In order to facilitate usage and uptake, we deliberately simplified 
the scoring system using a point-based approach. We will also be creating a more precise model 
using the original coefficients of the model, which will be available in App form. 
 
Study limitations 
Our analysis was performed on registry data in the absence of independent verification by core 
laboratory. Lack of external validation is a limiting factor in our analysis. In addition, while 
procedural outcome was obtained in all cases, data collection on variables was incomplete. 
However the amount of missing data did not exceed 10% for any variable. Angiographic data 
was obtained by visual assessment rather than by quantitative coronary analysis. Thus we 
cannot eliminate operator-related bias. Data was collected from high volume centres with highly 
skilled operators at CTO-PCI. Our model may not apply to centres where operator experience is 
lower. The failure rate for CTO PCI fell gradually during the course of the study, therefore the 
predictive failure rates are marginally higher than those seen in the final year of the Registry.  
 
CONCLUSIONS 
The EuroCTO (CASTLE) prediction score is a multi-centre derived scoring system to predict 
technical failure in the percutaneous treatment of CTO. Previous CABG, age over 70, a blunt 
stump, severe tortuosity, length of the occlusion and extent of calcification were strongly 
associated with unsuccessful CTO-PCI.  
 
FUNDING SOURCES: 
None 
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CLINICAL PERSPECTIVES 
 
WHAT IS KNOWN?  
 
Interventional treatment of chronic total coronary occlusions is a developing subspecialty. 
Demographic and anatomical criteria which can predict outcome have been derived from 
relatively modest sample sizes and not been subject to extensive contemporary data analysis 
 
WHAT IS NEW?  
 
We examined data from the EuroCTO Registry of 20,000 prospectively-entered cases from 
dedicated CTO operators and created a simple integer scoring system to predict technical 
outcome. The following factors were found to be of greatest importance - CABG history; Age; 
Stump anatomy; Tortuosity degree; Length of occlusion and Extent of calcification (CASTLE). 
Technical failure rates range from 8% (CASTLE score 0-1) to 35% (CASTLE score ≥4). 
 
WHAT IS NEXT? 
The predictive ability of our model needs to be validated in future studies 
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FIGURE LEGENDS 
 
Figure 1. Risk scores and predicted probabilities of failure of PCI for patients in the Euro-CTO 
derivation data set from years 2008 – 2014. The graph represents the distribution of total risk 
scores of 14882 patients with CTO. The red line shows the predicted surgical failures. 
 
Figure 2. Model calibration in Euro-CTO derivation data set from years 2008 – 2014 (N = 
14882). Comparison of the observed and predicted probabilities of failure of PCI across the four 
risk groups. 
 
Figure 3 Risk scores and calibration of the CASTLE model in the Euro-CTO validation data set 
from years 2015 and 2016. (a) Distribution of the risk scores of 5745 patients with CTO. (b) 
Comparison of the observed and predicted probabilities of failure of PCI computed by the 
EuroCTO CASTLE model across the four risk groups. 
Figure 4. Annual failure rates of PCI of CTO from years 2008 to 2016. The 
decreasing trend year on year in the observed annual failure rates was 
statistically evaluated with trend test (p < 0.001). 
 
Figure 5. Comparison of the observed risk scores and the adjusted predicted 
risk scores on the Euro-CTO validation data set from years 2015 and 2016 (N = 
5745). The CASTLE model was adjusted for the effect of time on failure rate 
before computing the predicted failure rate of PCI.  
